SATB1 was originally characterized as a regulator in T cell differentiation, found to be overexpressed in metastatic breast cancer cell lines and in human tissue specimens from advanced stages of breast carcinomas with metastasis[2,4,19-21]. Here, SATB1 is linked to breast carcinoma.